AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $860,888 | -9.9% | 369,480 | -8.0% | 0.01% | -7.1% |
Q2 2023 | $955,560 | +19.8% | 401,496 | -7.4% | 0.01% | +7.7% |
Q1 2023 | $797,944 | -13.0% | 433,665 | -10.1% | 0.01% | -13.3% |
Q4 2022 | $917,039 | +19.4% | 482,652 | +34.4% | 0.02% | +7.1% |
Q3 2022 | $768,000 | -25.7% | 359,110 | -1.7% | 0.01% | -30.0% |
Q2 2022 | $1,034,000 | – | 365,407 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |